Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Certain gene combinations may affect prostate cancer risk, and GSTP1 methylation is linked to tumor aggressiveness.

Male pattern baldness does not cause an increased risk of prostate cancer.

Men with baldness on the top of their head might have a small increased risk of prostate cancer.

Early baldness and little chest hair may indicate higher prostate cancer risk.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

CT scans can find serious prostate cancer even when PSA levels are low.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

The role of 5α-reductase-3 in prostate cancer is unclear and needs more research.

There might be a link between male pattern baldness and a higher risk of prostate cancer and testicular cancer.

Early-onset male baldness may indicate a higher risk of prostate cancer.

Early baldness in men may indicate a higher risk of prostate cancer.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Baldness (androgenic alopecia) could be a risk factor for prostate cancer.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Male pattern baldness may predict prostate cancer risk.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

CEC levels may be a useful marker for predicting prostate cancer progression.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Certain genetic markers can indicate a person's risk of developing prostate cancer.